Cargando…
Initial risk stratification and staging in prostate cancer with prostatic-specific membrane antigen positron emission tomography/computed tomography: A first-stop-shop
Current imaging for prostate cancer (PCa) had limitations for risk stratification and staging. Magnetic resonance imaging frequently underestimated lymph node metastasis while bone scintigraphy often had diagnostic dilemmas. Prostatic-specific membrane antigen (PSMA) positron emission tomography-com...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6216727/ https://www.ncbi.nlm.nih.gov/pubmed/30505224 http://dx.doi.org/10.4103/wjnm.WJNM_79_17 |
_version_ | 1783368301835976704 |
---|---|
author | Gupta, Manoj Choudhury, Partha Sarathi Rawal, Sudhir Goel, Harish Chandra Talwar, Vineet Singh, Amitabh Sahoo, Saroj Kumar |
author_facet | Gupta, Manoj Choudhury, Partha Sarathi Rawal, Sudhir Goel, Harish Chandra Talwar, Vineet Singh, Amitabh Sahoo, Saroj Kumar |
author_sort | Gupta, Manoj |
collection | PubMed |
description | Current imaging for prostate cancer (PCa) had limitations for risk stratification and staging. Magnetic resonance imaging frequently underestimated lymph node metastasis while bone scintigraphy often had diagnostic dilemmas. Prostatic-specific membrane antigen (PSMA) positron emission tomography-computed tomography (PET/CT) has been remarkable in PCa recurrence. Ninety-seven PSMA PET-CT scans were reanalyzed for tumor node metastases staging and risk stratification of lymph node and distant metastasis proportion. Histopathology of 23/97 patients was available as gold standard. Chi-square test was used for proportion comparison. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), overestimation, underestimation, and correct estimation of T and N stages were calculated. Kappa coefficient (κ) was derived for inter-rater agreement. Lymph node or distant metastasis detection on PSMA PET/CT increased significantly with increase in risk category. PSMA PET/CT sensitivity, specificity, PPV, and NPV for extraprostatic extension, seminal vesicle invasion, and lymph node metastases were 63.16%, 100%, 100%, 36.36%; 55%, 100%, 100%, 25%; and 65.62%, 99.31%, 87.50%, and 97.53%, respectively. Kappa coefficient showed substantial agreement between PSMA PET/CT and histopathological lymph node metastases (κ = 0.734); however, it was just in fair agreement (κ = 0.277) with T stage. PSMA PET/CT overestimated, underestimated, and correct estimated T and N stages in 8.71%, 39.13%, 52.17% and 8.71%, 4.35%, and 86.96% cases, respectively. PSMA PET/CT has potential for initial risk stratification with reasonable correct N stage estimation, however underestimates T stage. Hence, we concluded that PSMA PET/CT should be used as “ first-stop-shop” for staging and initial risk stratification of PCa with regional magnetic resonance imaging in surgically resectable cases. |
format | Online Article Text |
id | pubmed-6216727 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-62167272018-11-30 Initial risk stratification and staging in prostate cancer with prostatic-specific membrane antigen positron emission tomography/computed tomography: A first-stop-shop Gupta, Manoj Choudhury, Partha Sarathi Rawal, Sudhir Goel, Harish Chandra Talwar, Vineet Singh, Amitabh Sahoo, Saroj Kumar World J Nucl Med Original Article Current imaging for prostate cancer (PCa) had limitations for risk stratification and staging. Magnetic resonance imaging frequently underestimated lymph node metastasis while bone scintigraphy often had diagnostic dilemmas. Prostatic-specific membrane antigen (PSMA) positron emission tomography-computed tomography (PET/CT) has been remarkable in PCa recurrence. Ninety-seven PSMA PET-CT scans were reanalyzed for tumor node metastases staging and risk stratification of lymph node and distant metastasis proportion. Histopathology of 23/97 patients was available as gold standard. Chi-square test was used for proportion comparison. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), overestimation, underestimation, and correct estimation of T and N stages were calculated. Kappa coefficient (κ) was derived for inter-rater agreement. Lymph node or distant metastasis detection on PSMA PET/CT increased significantly with increase in risk category. PSMA PET/CT sensitivity, specificity, PPV, and NPV for extraprostatic extension, seminal vesicle invasion, and lymph node metastases were 63.16%, 100%, 100%, 36.36%; 55%, 100%, 100%, 25%; and 65.62%, 99.31%, 87.50%, and 97.53%, respectively. Kappa coefficient showed substantial agreement between PSMA PET/CT and histopathological lymph node metastases (κ = 0.734); however, it was just in fair agreement (κ = 0.277) with T stage. PSMA PET/CT overestimated, underestimated, and correct estimated T and N stages in 8.71%, 39.13%, 52.17% and 8.71%, 4.35%, and 86.96% cases, respectively. PSMA PET/CT has potential for initial risk stratification with reasonable correct N stage estimation, however underestimates T stage. Hence, we concluded that PSMA PET/CT should be used as “ first-stop-shop” for staging and initial risk stratification of PCa with regional magnetic resonance imaging in surgically resectable cases. Medknow Publications & Media Pvt Ltd 2018 /pmc/articles/PMC6216727/ /pubmed/30505224 http://dx.doi.org/10.4103/wjnm.WJNM_79_17 Text en Copyright: © 2018 World Journal of Nuclear Medicine http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Gupta, Manoj Choudhury, Partha Sarathi Rawal, Sudhir Goel, Harish Chandra Talwar, Vineet Singh, Amitabh Sahoo, Saroj Kumar Initial risk stratification and staging in prostate cancer with prostatic-specific membrane antigen positron emission tomography/computed tomography: A first-stop-shop |
title | Initial risk stratification and staging in prostate cancer with prostatic-specific membrane antigen positron emission tomography/computed tomography: A first-stop-shop |
title_full | Initial risk stratification and staging in prostate cancer with prostatic-specific membrane antigen positron emission tomography/computed tomography: A first-stop-shop |
title_fullStr | Initial risk stratification and staging in prostate cancer with prostatic-specific membrane antigen positron emission tomography/computed tomography: A first-stop-shop |
title_full_unstemmed | Initial risk stratification and staging in prostate cancer with prostatic-specific membrane antigen positron emission tomography/computed tomography: A first-stop-shop |
title_short | Initial risk stratification and staging in prostate cancer with prostatic-specific membrane antigen positron emission tomography/computed tomography: A first-stop-shop |
title_sort | initial risk stratification and staging in prostate cancer with prostatic-specific membrane antigen positron emission tomography/computed tomography: a first-stop-shop |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6216727/ https://www.ncbi.nlm.nih.gov/pubmed/30505224 http://dx.doi.org/10.4103/wjnm.WJNM_79_17 |
work_keys_str_mv | AT guptamanoj initialriskstratificationandstaginginprostatecancerwithprostaticspecificmembraneantigenpositronemissiontomographycomputedtomographyafirststopshop AT choudhuryparthasarathi initialriskstratificationandstaginginprostatecancerwithprostaticspecificmembraneantigenpositronemissiontomographycomputedtomographyafirststopshop AT rawalsudhir initialriskstratificationandstaginginprostatecancerwithprostaticspecificmembraneantigenpositronemissiontomographycomputedtomographyafirststopshop AT goelharishchandra initialriskstratificationandstaginginprostatecancerwithprostaticspecificmembraneantigenpositronemissiontomographycomputedtomographyafirststopshop AT talwarvineet initialriskstratificationandstaginginprostatecancerwithprostaticspecificmembraneantigenpositronemissiontomographycomputedtomographyafirststopshop AT singhamitabh initialriskstratificationandstaginginprostatecancerwithprostaticspecificmembraneantigenpositronemissiontomographycomputedtomographyafirststopshop AT sahoosarojkumar initialriskstratificationandstaginginprostatecancerwithprostaticspecificmembraneantigenpositronemissiontomographycomputedtomographyafirststopshop |